This inventor holds 2 USPTO granted patents. Top assignees: Chemgen Corporation, Other. Active years: 1991-1992.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1991-1992
Title: Innovations of Steven D Geusz in Bacterial Metabolism
Introduction
Steven D Geusz, an innovative inventor based in Silver Spring, MD, has made significant contributions to the field of biotechnology through his inventive work on bacterial metabolism. Holding two patents, Geusz focuses on utilizing bacteria to create pathways for the effective breakdown of phenylacetate, a compound often found in various chemical processes.
Latest Patents
Geusz's latest patents revolve around a novel process for using bacteria to metabolize phenylacetate through a mandelate-to-cis,cis-muconate pathway. These patents disclose a method for isolating bacteria that can utilize both L-phenylalanine and mandelate as the sole carbon sources. By strategically blocking other pathways involved in L-phenylalanine degradation, Geusz's innovative approach enables the accumulation of specific intermediates, enhancing the efficiency of biochemical processes involving phenylacetate.
Career Highlights
Throughout his career, Steven D Geusz has demonstrated exceptional expertise in microbiology and biochemistry, contributing to advancements in biotechnological applications. His work has the potential to impact various industries, including environmental remediation and chemical production.
Collaborations
Geusz has had the opportunity to collaborate with professionals like David M Anderson, further enriching his research endeavors. Additionally, he has worked with Chemgen Corporation, where he has applied his innovative ideas in practical settings, contributing to the development of beneficial microbial processes.
Conclusion
In summary, Steven D Geusz stands out as an inventive force in the realm of bacterial metabolism. With his significant patents focusing on phenylacetate metabolism, he is paving the way for new biotechnological applications that can revolutionize the industry. His collaborative work and dedication to innovation continue to make a lasting impact in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile